Tenaya Therapeutics, Inc. (TNYA) Tops Q4 EPS by 3c

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q4 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• Evercore ISI Reiterates Underperform Rating on Lennar (LEN)
• XORTX to voluntarily delist from TSX Venture Exchange
• 22nd Century Group files prospectus for warrant share resale